Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 3, 2016, Pages 564-570

  Barba, P ^a,b   Burns, L J ^c   Litzow, M R ^d   Juckett, M B ^e   Komanduri, K V ^f   Lee, S J ^g   Devlin, S M ^a   Costa, L J ^h   Khan, S ^d   King, A ⁱ   Klein, A ⁱ   Krishnan, A ^j   Malone, A ^k   Mir, M ^l   Moravec, C ^g   Selby, G ^m   Roy, V ⁿ   Cochran, M ^o   Stricherz, M K ^c   Westmoreland, M D ^p   Perales, M A ^a   Wood, W A ^q   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g USA   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

^j Department of Hematology and Hematopoietic Cell Transplantation ^*  (United States)

^k MOUNT SINAI MEDICAL CENTER   (United States)

^l PENN STATE CANCER INSTITUTE   (United States)

^m UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

ⁿ MAYO CLINIC   (United States)

^o DANA FARBER CANCER INSTITUTE   (United States)

^p UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^q UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Allogeneic hematopoietic stem cell transplantation; Autologous stem cell transplantation; Case discussions

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; POSTOPERATIVE COMPLICATION; TREATMENT INDICATION; UNITED STATES; ALLOGRAFT; AUTOGRAFT; HEMATOLOGIC NEOPLASMS;

ALLOGRAFTS; AUTOGRAFTS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 85009453056     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.12.008     Document Type: Article

References (21)

1. 1 Pasquini, M.C., Zhu, X., Current uses and outcomes of hematopoietic stem cell transplantation: 2014 CIBMTR Summary Slides. 2014 Available at: http://www.cibmtr.org.
2. 2 Majhail, N.S., Chitphakdithai, P., Logan, B., et al. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biol Blood Marrow Transplant 21 (2015), 142–150.
3. 3 Majhail, N.S., Farnia, S.H., Carpenter, P.A., et al. Indications for autologous and allogeneic hematopoietic cell transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21 (2015), 1863–1869.
4. 4 Oliansky, D.M., Camitta, B., Gaynon, P., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement. Biol Blood Marrow Transplant 18 (2012), 979–981.
5. 5 Oliansky, D.M., Camitta, B., Gaynon, P., et al. Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. Biol Blood Marrow Transplant 18 (2012), 505–522.
6. 6 Oliansky, D.M., Czuczman, M., Fisher, R.I., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biol Blood Marrow Transplant 17 (2011), 20–47.e30.
7. 7 Oliansky, D.M., Gordon, L.I., King, J., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review. Biol Blood Marrow Transplant 16 (2010), 443–468.
8. 8 Oliansky, D.M., Larson, R.A., Weisdorf, D., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review. Biol Blood Marrow Transplant 18 (2012), 16–17.
9. 9 Perales, M.A., Ceberio, I., Armand, P., et al. Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21 (2015), 971–983.
10. 10 Shah, N., Callander, N., Ganguly, S., et al. Hematopoietic stem cell transplantation for multiple myeloma: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21 (2015), 1155–1166.
11. 11 Giralt, S., Costa, L., Schriber, J., et al. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant 20 (2014), 295–308.
12. 12 Duong, H.K., Savani, B.N., Copelan, E., et al. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 20 (2014), 1262–1273.
13. 13 Bubalo, J., Carpenter, P.A., Majhail, N., et al. Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee. Biol Blood Marrow Transplant 20 (2014), 600–616.
14. 14 Lee, S.J., Joffe, S., Artz, A.S., et al. Individual physician practice variation in hematopoietic cell transplantation. J Clin Oncol 26 (2008), 2162–2170.
15. 15 Lee, S.J., Astigarraga, C.C., Eapen, M., et al. Variation in supportive care practices in hematopoietic cell transplantation. Biol Blood Marrow Transplant 14 (2008), 1231–1238.
16. 16 Pidala, J., Craig, B.M., Lee, S.J., et al. Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48 (2013), 63–67.
17. 17 Pidala, J., Lee, S.J., Quinn, G., et al. Variation in management of immune suppression after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17 (2011), 1528–1536.
18. 18 Khera, N., Zeliadt, S.B., Lee, S.J., Economics of hematopoietic cell transplantation. Blood 120 (2012), 1545–1551.
19. 19 Khera, N., Chang, Y.H., Hashmi, S., et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 20 (2014), 1375–1381.
20. 20 Abernethy, A.P., Etheredge, L.M., Ganz, P.A., et al. Rapid-learning system for cancer care. J Clin Oncol 28 (2010), 4268–4274.
21. 21 Institute of Medicine, Best care at lower cost: the path to continuously learning health care in America. 2013, The National Academies Press, Washington D.C.